Apple Watch warns 0.5% of users; Amarin’s Vascepa also helps prevent second and third heart attacks; Ohio sues OptumRx for overcharging for drugs.
FDA fast-tracks Purdue opioid-overdose treatment; India tries to block Juul’s entry into the country; Gottlieb calls on industry to adopt modernized clinical-trial approaches.
Jury awards $29 million in J&J talc case; Mental health disorders linked to social media; The rundown on Haven.
FDA proposes more e-cigarette regulations; Congress invites PBMs to Hill; Novo, AstraZeneca pull ads from Fox News.
National Cancer Institute head named acting FDA chief; United Health plans to pass PBM rebates to consumers; Drug prices tally biggest one-month drop ever in February.
Trump budget includes e-cigarette “user fee;” 23andMe to test for type 2 diabetes; FDA approves expanded use of Regeneron-Sanofi eczema drug.
The latest from South by Southwest; Feds investigate new Shkreli reports; Roche wins FDA approval of Tecentriq to treat aggressive breast cancer.
Juul pitches itself as smoking-cessation company; Shkreli plans a comeback; What’s next for the FDA?
Amazon names its healthcare venture Haven; BMS urges investors to back Celgene deal; Advisory council wants Canadian national drug agency; The latest edition of The MM&M Podcast.
Gottlieb to quit FDA; Five of pharma’s top digital innovators; Matter launches dedicated healthcare shop.
MM&M/Deloitte survey finds 26% jump in healthcare marketing budgets; Purdue considers Chapter 11; FDA slams retailers for teen tobacco sales.
Karen Newmark on bringing her marketing background to POC; Schiff calls out Amazon over vaccine content; CVS closes hearing centers.